If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Get Updates
219
Followers on Owler
Sage Therapeutics
is a biotechnology firm that develops and commercializes novel therapies for the treatment of CNS and neurodegenerative disorders...
Read more
Overview
Competitors
Funding
News & Insights
Sage Therapeutics
is a biotechnology firm that develops and commercializes novel therapies for the treatment of CNS and neurodegenerative disorders...
Read more
CEO
Barry E. Greene
CEO Approval Rating
83/100
Weigh In
2010
Cambridge
Massachusetts
Greater Boston
Public
NASDAQ
SAGE
Pharmaceuticals & Biotechnology
Biotechnology
2834
2836
NAICS listing
https://www.sagerx.com/
Annual Revenue
$47.4M
Employees
690
Funding
$843M
News
Key Events
Latest News
Conference Presentation
Jan 08, 2025
Benzinga
Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
Layoffs
Nov 01, 2024
The Business Journals
Cambridge biotech's layoffs will cut dozens of Mass. employees
Follow and Get Alerts
Sage Therapeutics Competitors
1
Follow
2
Follow
Unlock -1 + competitors
Trending Companies
